Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.320
0.00 (0.00%)
At close: Feb 19, 2026, 4:00 PM EST
2.282
-0.038 (-1.62%)
After-hours: Feb 19, 2026, 5:45 PM EST
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $214.08 million as of February 19, 2026. Its market cap has increased by 173.68% in one year.
Market Cap
214.08M
Enterprise Value
134.52M
1-Year Change
173.68%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $214.08M, an increase of 319.53%. That is a compound annual growth rate of 39.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 213.16M | 57.82% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 227.20M |
| Achieve Life Sciences | 225.71M |
| Cibus | 220.23M |
| Humacyte | 220.02M |
| Heron Therapeutics | 218.20M |
| Orchestra BioMed Holdings | 216.82M |
| Alector | 215.03M |
| Surrozen | 212.14M |